Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

May 6, 2020 Leave a comment 1,658 Views

Organicell Regenerative Medicine, Inc. a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: IND application

Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

COVID-19 and extracellular vesicles – an intriguing interplay

Anchor, spacer, and ligand-modified engineered exosomes for trackable targeted therapy

Upcoming Webinar – Ferrohydrodynamic isolation of circulating tumor cells and exosomes

Plasmonic olocrimetric biosensor for sensitive exosome detection

Development of a simple, sensitive and selective colorimetric aptasensor for the detection of cancer-derived exosomes

miR Scientific announces FDA breakthrough device designation for its prostate cancer liquid biopsy test